Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells. [electronic resource]
Producer: 20160129Description: 1683-90 p. digitalISSN:- 1791-2431
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Carcinoma -- drug therapy
- Cell Line, Tumor
- Cell Movement -- drug effects
- Deoxycytidine -- administration & dosage
- Drug Synergism
- Gallbladder Neoplasms -- drug therapy
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Male
- Mice
- Mice, Nude
- NF-kappa B -- antagonists & inhibitors
- Neoplasm Invasiveness
- Neoplasm Proteins -- antagonists & inhibitors
- Random Allocation
- Signal Transduction -- drug effects
- Triterpenes -- administration & dosage
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.